Effects of Finasteride on Vascular Endothelial Growth Factor

January 2002 in “ Scandinavian Journal of Urology and Nephrology ”

S. Häggström, Niels Uldbjerg, Kirsten Møller, Eric L. N. Jensen, Lars Lund, Nielsen Je, Anders Bergh, J.-E. Damber

finasteride vascular endothelial growth factor VEGF angiogenesis Propecia

TLDR Finasteride reduces prostate bleeding by affecting blood vessel growth.

This study investigated the effects of finasteride on vascular endothelial growth factor (VEGF) in human benign prostatic hyperplasia (BPH) tissue. The results showed that finasteride decreased the expression of VEGF in BPH tissue, but did not significantly affect microvessel densities or serum VEGF levels. The study suggests that finasteride may reduce prostate bleeding in BPH patients by affecting local angiogenesis and the associated increase in vascular permeability.

View this study on tandfonline.com →

Effects of Finasteride on Vascular Endothelial Growth Factor

Cited in this study

research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

research The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia

Related

research Effects of Finasteride on Vascular Endothelial Growth Factor